ARGEMONE MEXICANA LINN. HAVING MEDICINAL PROPERTY: REVIEW

ARGEMONE MEXICANA LINN. HAVING MEDICINAL PROPERTY: REVIEW

Vishal Hindurao Thorat ^* and Sachin Ghorpade

Department of Pharmacognosy, Government College of Pharmacy, Amravati SGB University, Amravati - 444604, Maharashtra, India.

ABSTRACT: Argemone mexicana Linn. has been reported to possess antimicrobial, cytotoxic, antimalarial and other pharmacological activity. The present study was found to be alkaloids, amino acids, phenolics, and fatty acids are isolated by using different exaction methods of isolation and characterization use to determine. The present article reviews the pharmacological and phytochemical work done on the plant and determines a scientific base for novel study for future research to establish toxin free response of plant or its phytoconstituents.

Antimicrobial activity, Wound healing, Antimalarial

INTRODUCTION: Argemone mexicana Linn. (Papaveraceae) is a common plant found everywhere by road-sides and fields in India. The plant, Argemone mexicana Linn. belonging to the family Papaveraceae, is a widely distributed plant throughout the subtropical and tropical regions of the world. It is commonly known as ‘Mexican prickly poppy,’ and ‘Satyanashi’ is a common name, it is a well-known weed in the agricultural and wastelands. It is an erect, prickly annual herb, up to 1.2 meters in height, naturalized throughout India up to an altitude of 1,500 meters. Leaves are sessile, semi-amplexicaul, sinuately pinnatifid, and spiny on margins, mid-rib and veins beneath; flowers yellow; capsules elliptic or oblong, prickly, rarely unarmed; seeds small, round, blackish brown, deeply reticulate-scrobiculate. The various part of the plant reported to possess potent emetic; narcotic activities and traditionally been used to

Treat, syphilis and skin-diseases ¹. Seeds are useful in cough and asthma. Seeds are laxative, nauseant, emetic, expectorant, and demulcent. The root is an antihelmintic ². Chemical investigations of this plant have revealed the presence of alkaloids, amino acids ³, phenolics, and fatty acids ⁴. The plant contains alkaloids as berberine, protopine, sanguinarine, optimize, chelerythrine, etc. The seed oil contains myristic, palmitic, oleic, linoleic acids, etc. The yellow juice containing small quantities of berberine, potassium nitrate was identified among the salts naturally existing in the plant. Two aliphatic compounds; mexicanol and mexicanic acid have been isolated from leaves. Three isoquinoline alkaloids have been isolated as dihydropalmitine hydroxide; berberine and protopine, from the seeds. Oil contains up to 40% free glycerides of fatty acids ⁵.

The plant Argemone mexicana traditionally used as a potent diuretic agent. Along with the plant shows anti anti-helmintic, anti-inflammatory, wound healing, anti bacterial, antifungal ⁶. The plant is bitter, acrid, cooling, vulnerary, purgative, inflammatory, expectorant, aphrodisiac, emetic, depurative, anodyne, anthelmintic, antipyretic, ophthalmic, stomachic and sedative. It cures leprosy, skin - diseases, inflammation and bilious fevers. Roots are useful in guinea-worm infestation, skin diseases, leprosy, pruritus, blennorrhagia, inflammations, all type of poisoning, constipation, flatulence, colic, malarial fever, and vestibular calculus. The leaves are useful in cough, wounds, ulcers and skin diseases. The juice is used to cure ophthalmia and opacity of the cornea. Seeds are purgative and sedative. Seeds resemble mustard seeds, and in India, it is used to adulterate mustard seed. Seeds are also useful in vitiated conditions of cough, asthma, pertussis, skin diseases, leprosy, wounds, odontalgia, dental caries, constipation, rheumatalgia, colic, and flatulence. The latex is useful in dropsy, jaundice, skin diseases, leprosy, blisters, conjunctivitis, inflammation, burning sensation, and malarial fever.

The oil is useful in indolent ulcers, wounds, leprosy and skin diseases, constipation, flatulence, colic, and rheumatologic. In the Homeopathic system of medicine, the drug prepared from this herb is used to treat the problem caused by the tapeworm. Seed yield nonedible toxic oil and causes lethal dropsy when used with mustard oil for cooking and show lots of toxic effect ⁷. Hepatotoxicities of varied etiology are widely encountered among the people of the entire world irrespective of the age, ethnic, racial, environmental and geographical variability.

The reasons are broad ranging from drugs or substance-induced to various metabolic and physiological disturbances, becoming one of the ten leading causes of death across the world hence, there is a way  or great hope to do toxicity study and determine the dose for claimed pharmacological activity  and if some constituents are responsible for toxicity, so it’s not meant that the whole plant is responsible for different toxicity because plant and its part are responsible for other pharmacological activity. So there is a hope to identify and isolate various phytoconstituents in this plant for above mentions or related pharmacological activity and scope to check lots of pharmacological activity in various or low dose or calculated dose according to toxicity study. Currently, researches are going on Argemone mexicana have focused on its hepatoprotective activity, anti microbial ⁸, cytotoxic ⁹ and anti HIV activity ¹⁰.

Plant Profile:

Argemone mexicana:

FIG. 1: ARGEMONE MEXICANA

General Description: Scientific name with Author Argemone mexicana Linn.:

Synonyms: Argemone leiocarpa Greene; Argemone ochroleuca Sweet; Echtrus trivialise Lour.; Echtrus mexicanus (L.) Nieuwl.; Argemone vulgaris Spach; Argemone versicolor Salisb.; Argemone spinosa Moench; Argemone sexvalis Stokes; Argemone mucronata Dum. Cours. ex Steud.; Argemone mexicana var. typica Prain; Argemone mexicana var. parviflora Kuntze; Argemone mexicana var. ochroleuca (Sweet) Lindl.; Argemone mexicana var. lutea Kuntze; Argemone mexicana fo. leiocarpa (Greene) G.B. Ownbey (Pires, 2009).

Family: Papaveraceae.

Vernacular Names: Mexican poppy, prickly poppy, yellow thistle, Mexican thistle (En). Argémone, pavot épineux, pavot du Mexique, tache de l’œil, chardon du pays (Fr) (Bosch, 2008).

Botanical Description: Argemone mexicana is an annual herb, growing up to 150 cm with a slightly branched taproot. Its stem is branched and usually extremely prickly. It exudes a yellow juice when cut. It has showy yellow flowers. Leaves are thistle-like and alternate, without leaf stalks (petioles), toothed (serrated) and the margins are spiny. The grey-white veins stand out against the bluish-green upper leaf surface. The stem is oblong in cross-section. Flowers are at the tips of the branches (are terminal) and solitary, yellow and of 2.5-5 cm diameter. The fruit is a prickly oblong or egg-shaped (ovoid) capsule. Seeds are very numerous, nearly spherical, covered in a fine network of veins, brownish black and about 1 mm in diameter (Nacoulma, 1996; Bosch, 2008).

Origin and Distribution: Argemone mexicana is native in Mexico and the West Indies, but has become pantropical after the accidental introduction or introduction as an ornamental. It is naturalized in most African countries, from Cape Verde east to Somalia, and south to South Africa (Bosch, 2008).

Distribution: Africa, Northeast Tropical Africa, Ethiopia, Socotra Asia-Temperate, Arabian Peninsula, North Yemen, Oman, Saudi Arabia, South Yemen Europe, Middle Europe, Austria, Germany, Switzerland, South-eastern Europe, Bulgaria , South-western Europe, France, Portugal, Spain Southern America, Brazil, Piaui, Northern South America, Venezuela, Southern South America, Paraguay, Western South America, Bolivia, Colombia, Ecuador .

Plant Part Used: Whole plant; Seeds; Seed oil; Flowers; Latex; Roots; Leaves.

Pharmacological Investigation:

Anti-malarial Activity: A prospective, dose-escalating, quasi-experimental clinical trial was conducted with a traditional healer using a decoction of Argemone mexicana for the treatment of malaria. The remedy was prescribed in three regimens: once daily for 3 days to group A; twice daily for 7 days to group B; and four times daily for the first 4 days followed by twice daily for 3 days to group C. Thus, 80 patients were included, of whom 80% were aged <5 years and 25% were aged <1 year. All presented to the traditional healer with symptoms of malaria and had a Plasmodium falciparum parasitemia>2000/μl but no signs of severe malaria. The proportions of adequate clinical response (ACR) at Day 14 were 35%, 73% and 65% in Groups A, B, and C, respectively (P = 0.011). At Day 14, overall proportions of ACR were lower in children aged <1 year (45%) and higher in patients aged >5 years (81%) (P = 0.027). Very few patients had complete parasite clearance, but at Day 14, 67% of patients with ACR had a parasitemia <2000/μl ¹⁵.

Anti-plasmodial Activity:  By the research 20 species, with low IC₅₀ values of 9-43 mg dry extract/ml have been shown to possess antiplasmodial activity in all of them, Argemone mexicana L. (Papaveraceae) also shown the same activity which is very by varying extract dose per kg/ body wt. concentration: In-vitro inhibition (%) of plant extracts against chloroquine susceptible strain of P. falciparum. The result shows: Mg dry extract / 80 mg part dry plant material 2.50, % Inhibition (mg: ml) according to dose i.e. 100 µg/ml (87); 50 µg/ml (76); 25 µg /ml (60); 12.5 µg / ml (51); and IC₅₀ µg /ml ¹⁶.

Larvicidal Activity: The acetone fraction of the petroleum ether extract of seeds from Argemone mexicana exhibited larvicidal and growth inhibiting activity against the second instar larvae of Aedes aegypti (Linn). This activity occurred at higher concentrations (200, 100, 50 and 25 ppm). Chemosterilant activity, including a reduction in blood meal utilization (27.70%), reduction in fecundity (19.00%), the formation of larval-pupal intermediates, the formation of pupal - adult intermediates, adult mortality and sterility of first generation eggs (100%), occurred at low concentration (10 ppm) ¹⁷.

Anti-bacterial Activity: The sensitivity of two gram-positive (Staphylococcus aureus and Bacillus subtilis) and two gram-negative (Escherichia coli and Pseudomonas aeruginosa) pathogenic multi-drug resistant bacteria was tested against the crude extracts (cold aqueous, hot aqueous, and methanol extracts) of leaves and seeds of Argemone mexicana L. (Papaveraceae) by agar well diffusion method.

Though all the extracts were found effective, yet the methanol extract showed maximum inhibition against the test microorganisms followed by hot aqueous extract and cold aqueous extract ¹⁸. The petroleum ether and alcoholic extracts of aerial parts of Argemone mexicana were evaluated for antimicrobial activity against 2 bacterial strains (gram-positive and negative), Bacillus subtilis and Escherichia coli. Both extracts showed high antimicrobial activity on the 2 pathogens, but the alcohol extract showed higher activity when compared to petroleum ether extract ¹⁹.

Cytotoxic Activity: The alkaloid isolated by fractionation of the chloroform extract from the aerial part of Argemone mexicana were evaluated for their cytotoxicity to human nasopharyngeal carcinoma (HONE-1) and human gastric cancer (NUGC) cell lines. Chelerythrine was found to exhibit significant activity against NUGC cell line, while angoline inhibited both types. (+)-Argenaxine showed moderate activity against the NUGC cell line ²⁰.

Wound Healing Activity: The wound healing effects of the leaf extract (50% ethanol) and latex of Argemone mexicana were investigated on albino rats using both excision and incision wound models. Topical application of the extract and latex, respectively, gave 67.08 and 57.86% healing after 12 days in the excision model and increased tensile strength to 188.50 and 154.61 gm in the incision model. However, both the extract and latex of A. mexicana were not as effective as the standard nitrofurazone in both excision and incision models ²¹.

Vasorelaxant Activity: The vascular effects of a methanolic extract of the aerial part Argemone mexicana was investigated in rat aortic rings. The extract produced relaxation from contraction induced by norepinephrine (NE: 1 × 10^-7 M) in a concentration-dependent manner (0.1 at 1000 μg/ml). At higher concentrations (310 and 1000 μg/ml), the extract induced significant additional tension. When applied to relaxed aortic tissue, the addition of the extract produced a concentration-dependent contraction.

Vasoconstrictor and vasorelaxant effects produced by the extract were not altered significantly in endothelium-denuded rings; however, phenoxi- benzamine (1 mg/ml) produced a rightward shift in the concentration–contractile response curve to the extract. On the other hand, the extract relaxed significantly the contraction induced by KCl (40 mM). The results indicate that the extract induces a direct dual specific effect upon the vascular smooth muscle, mediated, at least in part, by adrenergic receptors ²². The petroleum ether, CHCl₃, CHCl₃/ MeOH (9:1), MeOH extract and partially purified fractions and pure compounds from Argemone mexicana examined on the electrically induced contractions of the isolated guinea-pig ileum (E.C.I.). The results of the experiments indicate that CHCl₃ / MeOH (9:1) and MeOH extracts, tested at a concentration of 400, 200 and 100 mg/mL, dose-dependently reduced the guinea-pig ileum contractions, whereas the petroleum ether and CHCl₃ extracts did not affect it.

Furthermore, the partially purified fractions II-V from the MeOH extract, each tested at concentrations of 200, 100 and 50 mg/mL also inhibited E.C.I. Finally the pure compounds 1-2 (5×10^-6 - 1×10^-5 - 5×10^-5 M) isolated and purified from the above fractions significantly reduced, in a dose-dependent manner, the electrical contractions of the ileum, whereas compound 3 (5×10^-6 - 1×10^-5 × 10^-5 M) increased them. Since the active compounds 1-3 were respectively identified as protopine, allocryptopine and berberine by NMR, the observed effects could be related mainly to these compounds ²³.

Anti-asthmatic Activity: The research title, i.e. Medicinal plants used to treat asthma in Andhra Pradesh, India proved that Argemone mexicana L. (Papaveraceae) (common or local name:  Brahmadanda) Seed powder, 100 - 200 mg taken twice a day, for 2 weeks shows a significant effect on asthma as antiasthmatic activity ²⁴. Anti-stress and antiallergic effect of Argemone mexicana Stems in Asthma shows: Petroleum ether, acetone and methanol and aqueous extracts of Argemone mexicana stem (50 mg/kg, i.p.) were screened for its antiallergic and antistress potential in asthma by milk-induced leucocytosis and milk-induced eosinophilia.

Aqueous extracts showed significant (P < 0.05) decrease in leucocytes and eosinophils, methanol extract also showed comparable results with aqueous extract while petroleum ether and acetone extracts were inactive. This shows polar constituents of A. mexicana stem are responsible for the anti-stress and anti-allergic activity.

• Milk-induced leucocytosis: Amongst mice pretreated with various extracts of mexicana stem, aqueous and methanol extracts showed a significant reduction in leucocytes, induced by milk.
• Milk-induced eosinophilia: Amongst mice pretreated with various extracts of mexicana stem, aqueous and methanol extracts showed a significant reduction in eosinophil count ²⁵.

Anti-HIV Activity: The alkaloids isolated from methanolic extract of the Argemone mexicana were evaluated for anti-HIV activity. In which benzo[c] phenanthridine (+/-)- 6- acetonyl - dihydro chelerythrine exhibited significant anti-HIV activity in H9 lymphocytes with EC₅₀ and TI (Therapeutic Index) values of 1.77 µ /ml and 14.6, respectively ²⁶.

Hepatoprotective Activity: The root bark of Argemone mexicana was investigated on CCl4 (Carbon tetrachloride) induced liver damaged in rats. Acute toxicity study, efficacy study, blood and tissue biochemical assays like ALT, AST, bilirubin, total protein, glucose, LM and EM, etc. have been studied for evaluation of hepatoprotective action. From the above observations of biochemical parameters it was demonstrated that Argemone mexicana indeed has a high potential in healing liver parenchyma and regeneration of liver cells; hence it may act as a potent liver tonic ²⁷.

The protective effects of the aqueous extract of Argemone mexicana (Linn.) whole plant; against CCl4 induced hepatic failure in male albino rats (Wistar strain) was investigated. For the acute and massive invasion of hepatopathy, CCl₄ (i.p injection of CCl₄ + olive oil in 1:1 ratio; 2ml/kg) was used and various biochemical parameters followed by significant (p<0.001) weight loss in the toxic control group (-12.83 ± 1.13). The administration of aqueous extracts (250 mg/kg and 150 mg/kg of body weight) for 7 days, elicited protective action since the elevated levels of marker enzymes (AST, ALT, ALP) of liver functions were found to be decreasing progressively in a dose-dependent manner with net weight gain.

In the aqueous extract, 250 mg/kg treated rat group all the marker enzymes were analyzed to be decreasing significantly (p<0.001), (AST, 272.77 ± 24.08; ALT, 189.15 ± 7.16; ALP, 97.15 ± 6.54) and the final body weight was also significantly (p<0.001) increased (6.16 ± 1.01) when compared with the toxic control group. The total serum protein and the serum albumin were also approaching normal values. The results found in aqueous extract 250 mg/kg treated rat were quite promising and were comparable with a standard polyherbal drug Liv-52. The statistically processed results support the conclusion, that the aqueous extract of Argemone mexicana (Linn.) whole plant (250 mg/kg and 150 mg/kg) possesses dose-dependent, significant protective activity against CCl₄ induced hepatotoxicity ²⁸.

Molluscicidal Activity: Molluscicidal property of seeds of Argemone mexicana against snail Lymnaea acuminata was studied. It was observed that the molluscicidal activity of seed powder of A. mexicana, was both time and dose-dependent. Protopine and sanguinarine in the seed of A. mexicana were identified as the active moiety causing snail death by co-migration of the active agent with seed powder ²⁹.

Opoid Withdrawal: The MeOH extract, partially purified fraction (IV), and pure compounds from Argemone mexicana examined for its effect on the morphine withdrawal in guinea pig isolated ileum. The MeOH extract, the partially purified fraction (IV), and the pure compounds isolated from Argemone mexicana significantly and in a concentration-dependent manner reduced the morphine withdrawal. Since the pure compounds were identified as protopine and allocryptopine, the observed effects could be related to these compounds. The results of the present study suggest that isoquinoline alkaloids may be potential agents in the treatment of drug abuse ³⁰.

Toxicity and Safety Evaluation: The alkaloid sanguinarine isolated from seeds of Argemone mexicana was examined for its hepatotoxic potential in rats. The studies showed that a single i.p. dose (10 mg/kg) of sanguinarine not only increased the activity of SGPT and SGOT substantially but also caused a significant loss of microsomal cytochrome P-450 and benzphetamine N-methylase activity. Furthermore, the treated rats exhibited considerable loss of body and liver weight, peritoneal edema and slightly enlarged livers with fibrinous material. Microscopic examination of the liver tissue showed progressive cellular degeneration and necrosis further substantiating that sanguinarine is a potential hepatotoxic alkaloid ³¹.

Toxicolethal effects of seeds of Argemone mexicana were investigated in to roof rat, (Rattus rattus L.). The argemone seeds were fed at 100% of the diet up to the death or for a maximum of 10 days. Observed signs of poisoning were sedation, passiveness, sluggishness, feeble or no muscular jerks, abdominal contractions, and increased defecation. Also, black secretions from the eyes, corneal opacity, erection of hairs, and edema of the hind legs and submandibular space in were noted. Fourteen of 16 rats died. Significant reduction in the weights of the rats was observed. There were significant increases in blood glucose, BUN and SGOT. Major histopathological lesions were: hepatocytolysis, nuclear degeneration, pyknosis, cloudy swelling and dilatated sinusoids disturbing the lobular architecture of the liver; proliferated endothelium of glomeruli, hemorrhage in glomeruli and interstitium, and cloudy swelling of convoluted tubular epithelium in the kidney cortical region; erosion and atrophy of the upper stomach mucosa and calcification in the cardiac stomach, and; erosion and congestion of the upper mucosa of the duodenum. No change was noticed in the ileum ³². Safety evaluation studies on argemone oil through dietary exposure for 90 days in rats: Epidemic dropsy is a disease caused by the consumption of mustard oil contaminated with argemone oil (AO). During 1998 dropsy in New Delhi, which is so far the largest with more than 3000 victims and over 60 deaths, it was enquired at various scientific and regulatory meetings about the maximum tolerated dose of AO. Animals were given AO in the diet at a dose of 0.001%, 0.01%, 0.1%, 0.5%, and 1% daily for 90 days and the two control groups received the standard diet with and without 1% mustard oil.

A decrease in body weight gain (28-31%) was observed in 0.5% and 1% AO groups; while significant increases in relative lungs and liver weight were noticed in respective doses of 0.01% and 0.1% AO groups as well as in higher dosage animals. Reduction in RBC count and haemoglobin content (p < 0.05) was noticed in 0.01% and 0.1% AO exposed animals. This effect was more pronounced in higher AO doses. Serum marker enzymes including alanine transaminase (ALT), aspartate transaminase (AST), lactate dehydrogenase (LDH) and alkaline phosphatase (ALP) were found to be significantly elevated in 0.01–1% AO groups.

Further, a decrease in the albumin/globulin ratio (42 -78%) was observed in the serum of 0.01% to higher AO dose groups. The levels of serum triglycerides and VLDL cholesterol were found to be enhanced (p<0.05) in AO treated (0.01 - 1.0%) animals. Histopathological changes in the lung were observed at 0.01% dose of AO while liver, kidney and heart produced changes at 0.1% AO and above doses.

None of the parameters were found to be affected in 0.001% AO treated animals. These results suggest that the no observed adverse effect level (NOAEL) dose of AO is 0.001% in rats and considering a factor of 100 for humans for highly toxic compound, the safe limit of 0.00001% (100 ppb or 100 ng AO/g oil) AO can be implicated which shall contain only 0.55% of sanguinarine equivalent to 0.6 ng sanguinarine per gram oil. However, the minimum detectable limit of AO is 5 ppm (equivalent to 5 ng sanguinarine per gram oil) with the present existing HPLC method, thereby suggesting that mustard oil should be free from AO contamination ³³.

In-vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline Comet assay in mice: Consumption of mustard oil contaminated with argemone oil is well known to cause clinical manifestation referred to as ‘‘Epidemic Dropsy’’. Our prior studies have shown that argemone oil produces genotoxic effects in mice ³⁰. Since, sanguinarine alkaloid is the major component of argemone oil, the in-vivo DNA damaging potential of the isolated alkaloid was investigated in blood and bone marrow cells of mice using alkaline Comet assay. Swiss albino male mice were given single intraperitoneal administration of 1.35, 2.70, 5.40, 10.80 and 21.60 mg sanguinarine alkaloid/kg b.wt. while controls were treated with saline in the same manner.

The results revealed a dose-dependent increase in DNA damage in blood and bone marrow cells following 24 hr treatment of sanguinarine alkaloid. All the three parameters of Comet assay including olive tail moment (OTM), tail length and tail DNA showed significant (p<0.05) increases in blood and bone marrow cells at respective doses of 10.80 and 5.40 mg alkaloid/kg b.wt. However, some of the parameters were significantly increased even at lower doses of sanguinarine alkaloid (2.70 mg/kg but.). The frequency of cells exhibiting greater DNA damage was found to be increased by sanguinarine alkaloid in a concentration-dependent manner. These results indicate that single exposure of sanguinarine alkaloid causes DNA damage in blood and bone marrow cells of mice, which could be responsible for the genotoxicity of argemone oil.

The present study indicates that sanguinarine alkaloid, an active ingredient of argemone oil possesses DNA damaging potential in blood and bone marrow cells using alkaline comet assay. These results fully support the earlier observation that in-vivo argemone oil caused genotoxicity by enhancing the frequencies of chromosomal aberrations, micronuclei formation, and development of comets resulting in DNA damage ³⁰. In this regard, studies have shown that sanguinarine forms DNA adducts following metabolism by cytochrome P-450 system under in- vitro conditions ³⁴. It has been suggested that sanguinarine may undergo N-demethylation by cytochrome P-450 ³². Since, sanguinarine has been shown to cause inactivation of cytochrome P-450, it can be argued that the N-demethylated product of sanguinarine or any other electrophilic metabolite, could be responsible for this effect.

The decrease in cytochrome P-450 thereby impairs the elimination of a metabolite of sanguinarine, identified as benzacridine, in urine and feces. Although, minimum group of sanguinarine has been shown to have an affinity with b-form duplex DNA by intercalation with a high preference to G-C base pairs nonetheless, it could not reveal genotoxicity in SOS chromtest using E. coli PQ37 in the absence and presence of metabolic activation system. However, it raised the possibility of usage of sanguinaria extract in toothpaste in the development of oral leukoplakia ³⁵.

Phytochemical Evaluation: A large number of chemical constituents have been isolated and identified from various parts of Argemone mexicana including alkaloids, amino acids, phenolics, and fatty acids, the constituents of pharmacological importance are presented. Quaternary alkaloids of Argemone mexicana: Four quaternary isoquinoline alkaloids, dehydrocory- dalmine, jatrorrhizine, columbamine, and oxyber- berine, have been isolated from the whole plant of Argemone mexicana Linn. (Papaveraceae) and their structures established by spectral evidence. This is the first report of these alkaloids (dehydro-corydalmine, jatrorrhizine, columbamine, and oxyberberine) from Argemone mexicana and the Argemone genus ^{37, 38}.

CONCLUSION: The extensive survey literature reviewed that Argemone mexicana Linn. has some important medicinal activity but also cause considerable toxicity. Few novel chemical constituents isolated from the Argemone mexicana showed anti-HIV properties too. The present review studied that plant having the biological potential to treat the wound, cuts, antibacterial, hepatoprotective activity.

The present study was found to be alkaloids, amino acids, phenolics, and fatty acids are isolated by using different exaction methods of isolation and characterization use to determine. The present article reviews the pharmacological and phytochemical work done on the plant and determines a scientific base for novel study for future research to establish toxin free response of plant or its phytoconstituents.

ACKNOWLEDGEMENT: Nil

CONFLICT OF INTEREST: Nil

REFERENCES:

1. Krishnamurthy A: The wealth of India. Publication and information directorate, CSIR, New Delhi, Vol. VIII, 1969: 415-417.
2. Nadkarni KM: In Indian Materia Medica. Published by Bombay Popular Prakashan 1982; 1: 133.
3. Hussain SF, Nakkady S, Khan L and Shamma M: Oxyhydrastinine, an isoquinolone alkaloid Papaveraceae.  Phytochemistry 1983; 22(1): 319-320.
4. Harborne JB and Williams CA: Flavonoids in the seeds of Argemone mexicana: A reappraisal. Phytochemistry 1983; 22(6): 1520-1521.
5. Anonymous: In the Wealth of India A Dictionary of Indian Raw Materials and Industrial Products. Council of Scientific and Industrial Research, New Delhi 2004; 1: 86-87.
6. Bhattacharjee I, Chatterjee SK, Chatterjee S and Chandra G: Antibacterial potentiality of Argemone mexicana solvent extracts against some pathogenic bacteria.  Mem Inst Oswaldo Cruz 2006; 101(6): 645-8.
7. Habbu PV, Joshi H and Patil BS: Ph.cog Rev.: Review Article potential wound healers from plant origin. Pharmacognosy Reviews 2007; 1(2): 14-28.
8. Bhattacharjee I, Chatterjee SK, Chatterjee S and Chandra G: Antibacterial potentiality of Argemone mexicana solvent extracts against some pathogenic bacteria.  Mem Inst Oswaldo Cruz 2006; 101(6): 645-8.
9. Chang YC, Chang FR, Khalil AT, Hsieh PW and Wu YC: Cytotoxic benzophenanthridine and benzylisoquinoline alkaloids from Argemone mexicana.  Z Naturforsch 2003; 58(7-8): 521-6.
10. Chang YC, Hsieh PW, Chang FR, Liaw CC, Lee KH and Wu YC: Two new properties argemexicaines A and B and the anti-HIV alkloid 6-acetonyldihydrochelerythrine from  mexicana. Planta Medica 2003; 69: 148-152.
11. Bhardwaj DK, Bisht MS, Jain RK and Munjal A: Phenolics from the seeds of Argemone mexicana. Phytochemistry 1982; 21(8): 2154-2156.
12. Kirtikar KR and Basu BD: In Indian Medicinalplants.  Sri Satguru Publications, Delhi, Vol. I, Edition 2^nd, 1991: 129-131.
13. Orient Longman: Indian medicinal plants (a compendium of 500 species). 1998; 1: 186-187.
14. Rastogi RP and Mehotra BN: In Compendium of Indian Medicinal Plants. CDRI, Lucknow 1970-1979; 2: 446.
15. Willcox ML, Graz B, Falquet J, Sidibé O, Forster M and Diallo D: Argemone mexicana decoction for the treatment of uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 2007; 101(12): 1190-1198.
16. Simonsen HT, Nordskjold JB, Smitt UM, Nyman U, Palpu P, Joshi P and Varughese G: In-vitroscreening of Indian medicinal plants for anti-plasmodial activity. Journal of Ethnopharmacology 2001; 27: 195-204.
17. Sakthivadivel M and Thilagavathy D: Larvicidal and chemosterilant activity of the acetone fraction of petroleum ether extract from Argemone mexicana seed. Bioresource Technology 2003; 89(2): 213-216.
18. Bhattacharjee I, Chatterjee SK, Chatterjee S and Chandra G: Antibacterial potentiality of Argemone mexicana solvent extracts against some pathogenic bacteria.  Mem Inst Oswaldo Cruz 2006; 101(6): 645-8.
19. Sangameswaran B, Balakrishnan BR, Arul B and Jayakar B: Antimicrobial activity of aerial parts of Argemone mexicana Journal of Ecotoxicology and amp; Environmental Monitoring 2004; 14(2): 143-146.
20. Chang YC, Chang FR, Khalil AT, Hsieh PW and Wu YC: Cytotoxic benzophenanthridine and benzylisoquinoline alkaloids from Argemone mexicana.  Z Naturforsch 2003; 58(7-8): 521-6.
21. Ghosh S, Shirwaikar A and Rao PGM: Effect of Argemone mexicana leaves on wound healing in rats. Ind Jour of Natul Prod 2004; 45-48.
22. Páez-Sánchez E, Fernández-Saavedra G and Magos GA: Vasoconstrictor and Vasorelaxant effects of a Methanolic Extract from  mexicana Linn. (Papaveraceae) in Rat Aortic Rings, Proc. West Pharmacol Soc 2006; 49: 63-65.
23. Piacente S, Capasso A, Tommasi ND, Jativa C, Pizza C and Sorrentino L: Different Effects of some isoquinoline alkaloids from Argemone mexicanaon electrically induced contractions of isolated guinea-pig ileum. Phytotherapy Research 1997; 11(2): 155-157.
24. Savithramma I, Sulochana C and Rao NK: Ethnobotanical survey of plants used to treat asthma in Andhra Pradesh. India Journal of Ethnopharmacology 2007: 54-61.
25. Bhalke RD, Gosavi SA: Anti-stress and antiallergic effect of Argemone mexicana stems in asthma. Arch Pharm Sci and Res 2009; 1(1): 127-129.
26. Chang YC, Hsieh PW, Chang FR, Liaw CC, Lee KH and Wu YC: Two new properties argemexicaines A and B and the anti-HIV alkloid 6-acetonyldihydrochelerythrine from  Argemone mexicana. Planta Medica 2003; 69: 148-152.
27. Pingale SS, Pokharkar RD and Pingale MS: Effect of  mexicanaL. root bark on an evaluation of hepatoprotective action in rats. Pharmacologyonline 2008; 1: 13-19.
28. Das PK, Panda P, Pani SR and Sethi R: Hepatoprotective activity of plant Argemone mexicana(linn). Against carbon tetrachloride (CCl₄) induced hepatoxicity in rats. International Journal of Pharmaceutical Research and Development 2009; 8: 1-20.
29. Singh S and Singh DK: Molluscicidal property of seeds of  mexicana.Chemosphere 1999; 38(14): 3319-3328.
30. Capasso A, Piacente S, Pizza C, De Tommasi N, Jativa C and Sorrentino L: Isoquinoline alkaloids from Argemone mexicanareduce morphine withdrawal in guinea pig isolated ileum. Planta Med 1997; 63(4): 326-328.
31. Dalvil RR: Sanguinarine: its potential as a liver toxic alkaloid present in the seeds of Argemone mexicana.  Experientia 1985; 41(1): 77-78.
32. Pahwa R, Chatterjee VC: The toxicity of Mexican poppy Argemone mexicana seeds to rats. Vet Hum Toxicol 1989; 31(6): 555-558.
33. Babu CK, Khanna SK and Das M: Safety evaluation studies on argemone oil through dietary exposure for 90 days in rats. Food and Chemical Toxicology 2006; 44: 1151-1157.
34. Ansari KM, Dhawan A, Khanna SK and Das M: In-vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline Comet assay in mice. Food. Chem. Toxicol 2005; 43: 147-153.
35. Stiborová M, Šimánek V, Frei E, Hobza P and Ulrichová J: DNA adducts formation from quaternary benzo[c] phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-post labeling technique. Chem-Biol Interact 2002; 140: 231-242.
36. Das M and Khanna SK: Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil.  Crit Rev Toxicol 1997; 27: 273-297.
37. Papova ME, Boera AN, Dolejs L, Preiniger V, Simamek V and Santanvy F: Isolation and chemistry of alkaloids from plants of the Papaveraceae. Pant Med 1980; 40: 156.
    

    ---

    How to cite this article:

    Thorat VH and Ghorpade S: Argemone mexicana Linn. having medicinal property: review. Int J Pharmacognosy 2018; 5(2): 82-90. doi link: http://dx.doi.org/10.13040/IJPSR.0975-8232.IJP.5(2).82-90.

    ---

    This Journal licensed under a Creative Commons Attribution-Non-commercial-Share Alike 3.0 Unported License.

    ---